GB2115287A - Devices for replacing or assisting the heart - Google Patents
Devices for replacing or assisting the heart Download PDFInfo
- Publication number
- GB2115287A GB2115287A GB08218603A GB8218603A GB2115287A GB 2115287 A GB2115287 A GB 2115287A GB 08218603 A GB08218603 A GB 08218603A GB 8218603 A GB8218603 A GB 8218603A GB 2115287 A GB2115287 A GB 2115287A
- Authority
- GB
- United Kingdom
- Prior art keywords
- heart
- compressor
- blood
- mammalian
- muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 claims abstract description 23
- 210000004369 blood Anatomy 0.000 claims abstract description 23
- 238000005086 pumping Methods 0.000 claims abstract description 13
- 210000004165 myocardium Anatomy 0.000 claims description 14
- 230000009471 action Effects 0.000 claims description 11
- 230000001746 atrial effect Effects 0.000 claims description 10
- 230000002861 ventricular Effects 0.000 claims description 10
- 230000033001 locomotion Effects 0.000 claims description 8
- 210000004072 lung Anatomy 0.000 claims description 8
- 210000000709 aorta Anatomy 0.000 claims description 7
- 230000001276 controlling effect Effects 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 230000008602 contraction Effects 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 230000017531 blood circulation Effects 0.000 claims description 4
- 230000001020 rhythmical effect Effects 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 2
- 230000000747 cardiac effect Effects 0.000 claims description 2
- 238000000151 deposition Methods 0.000 claims description 2
- 230000002950 deficient Effects 0.000 claims 1
- 230000005672 electromagnetic field Effects 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 239000000306 component Substances 0.000 description 13
- 108091006146 Channels Proteins 0.000 description 7
- 210000004351 coronary vessel Anatomy 0.000 description 7
- 230000028161 membrane depolarization Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 210000002837 heart atrium Anatomy 0.000 description 5
- 210000005240 left ventricle Anatomy 0.000 description 5
- 230000036982 action potential Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 210000005245 right atrium Anatomy 0.000 description 4
- 210000001992 atrioventricular node Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- 210000001087 myotubule Anatomy 0.000 description 3
- 230000010349 pulsation Effects 0.000 description 3
- 210000005241 right ventricle Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 208000003663 ventricular fibrillation Diseases 0.000 description 3
- 206010003658 Atrial Fibrillation Diseases 0.000 description 2
- 241000272470 Circus Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010061592 cardiac fibrillation Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000002999 depolarising effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002600 fibrillogenic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000002336 repolarization Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010003662 Atrial flutter Diseases 0.000 description 1
- 206010015856 Extrasystoles Diseases 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 206010029470 Nodal rhythm Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010047289 Ventricular extrasystoles Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003157 atrial septum Anatomy 0.000 description 1
- 206010003668 atrial tachycardia Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001862 defibrillatory effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000009177 electrical depolarization Effects 0.000 description 1
- 230000005674 electromagnetic induction Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004457 myocytus nodalis Anatomy 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- GWUSZQUVEVMBPI-UHFFFAOYSA-N nimetazepam Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1 GWUSZQUVEVMBPI-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/845—Constructional details other than related to driving of extracorporeal blood pumps
- A61M60/851—Valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/104—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body
- A61M60/109—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/165—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
- A61M60/191—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart mechanically acting upon the outside of the patient's native heart, e.g. compressive structures placed around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/289—Devices for mechanical circulatory actuation assisting the residual heart function by means mechanically acting upon the patient's native heart or blood vessel structure, e.g. direct cardiac compression [DCC] devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/424—Details relating to driving for positive displacement blood pumps
- A61M60/457—Details relating to driving for positive displacement blood pumps the force acting on the blood contacting member being magnetic
- A61M60/462—Electromagnetic force
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/465—Details relating to driving for devices for mechanical circulatory actuation
- A61M60/489—Details relating to driving for devices for mechanical circulatory actuation the force acting on the actuation means being magnetic
- A61M60/495—Electromagnetic force
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
- A61M60/562—Electronic control means, e.g. for feedback regulation for making blood flow pulsatile in blood pumps that do not intrinsically create pulsatile flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/835—Constructional details other than related to driving of positive displacement blood pumps
- A61M60/837—Aspects of flexible displacement members, e.g. shapes or materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/839—Constructional details other than related to driving of devices for mechanical circulatory actuation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/876—Implantable batteries
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
Abstract
A device which may operate alone or in conjunction with the natural heart, comprises electromagnetically controlled blood pumping means.
Description
SPECIFICATION
Artificial heart
This invention relates to devices substituting for or assisting the heart, either corporally or extracorporally.
The bloodsupplytotheheartmuscle occursviathe coronary circulation. Defects in this area of the circulatory system are among the most common afflictions of mankind. When an increased amount of work is required of the heart, an increase in coronary blood flow must occur to provide for the additional oxygen requirements of the muscle fibers. The vessels in the coronary system differ from those in most of the rest of the body in that the major branches lie within contracting muscle fibers. External pressure by the myocardium during ventricular systole compresses the vessels and decreases blood flow, even though the aortic pressure is increased, 70 percent of coronary arterial flow therefore occurs during diastole.Compression of the vessels, however, hastens the discharge of venous blood due to squeezing on the veins. Outflow from the coronary veins is therefore greater in systole than in diastole.
The left coronary artery supplies most of the left ventricle and the anterior portion oftheventricular septum. The right coronary arterysuppliesthe right ventricle and the posterior portion of the septum.
Since the left coronary artery supplies a large portion of the left ventricle, occlusion of a major branch generally seriously damages the pumping ability of this high pressure chamber. The right coronary arterial system on the other hand, supplies a chamber that needs to produce only low pressures and may suffer considerable damage without significant impairment of its pumping ability. Branches from the right coronary system supply the SA (sino-atrial) and
AV (atriojventricular) nodal areas, however, and damage to these areas may produce life-threatening arrhythmias. In terms of relative flow distribution, about 85 percent of total coronary blood flow occurs through the left coronary artery and about 15 percent through the right coronary artery.Most of the venous return from the left coronary artery occurs through the great coronaryvein into the coronary sinus in the rightatrium; from the right coronary artery, venous return is via the anterior cardiac vein to the right atrium.
Cardiac muscle, like smooth muscle, skeletal muscle, and nerve, possesses a resting electrical potential relative to the ion distribution across the cell membrane. Like these tissues, it also has the ability to depolarize; depolarization (and repolarization) is manifested by a change in the electrical potential across the cell membrane. Most ofthe areas ofthe heart can depolarize spontaneously and thereby can contractwithout external nerve stimulation. This property of myocardial tissue is termed automaticity.
Normally, the depolarization and repolarization processes proceed in an orderly fashion through the hearttissue, producing a characteristic electrocardiographic pattern. The SA node, a group of specialized muscle cells derived from the area of junction of the embryonic sinusvenosus and the atrium, lies at the junction of the right atrium and the superiorvena cava. These cells tend to depolarize spontaneously faster than those in any other area of the heart. Hence they normally control the heart rate and are called pacemaker cells. If for some reason this area fails to be the most rapidly depolarizing, the pacemaker site shifts to other areas, such as theAV node, which lies at the lower posterior, right side of the atrial septum and gives rise to a group of specialized muscle fibers.
All of these specialized muscle cells have the property of automaticity and serveto conduct the electrical impulse rapidlythrough the heart.
Once the cell potential reaches threshold, the characteristic rapid action potential is produced. This action potential spreads out from the SA node over the surface of the atria, activating the normally quiescent atrial cells. These cells in turn depolarize, andthe impulse isthus passed totheAV nodal area.
The specialized cells in the AV node respond poorly, and conduction through this area is very slow. In somecasesthe impulse maynotgetthroughatall, resulting in a dropped beat or a shift to another pacemaker site. Normally, however, after a short delay, the impulse spreads outto activate the ventricular muscle. The action potentials of the conduction bundles and ventricular muscle cells differ from those ofthe pacemaker and atrial areas in possessing a long plateau phase of depolarization.
During this time the cell cannot be stimulated by another incoming action potential. This plateau phase lasts until the muscle contraction has been completed. Thus, unlike skeletal muscle, cardiac muscle cannot showtetanic contraction. This refractory ability is important in the heart's action as a mechanical pump to allow adequate time forfilling to occur.
Various abnormalities in the electrical activity of the heart resulting from damage to the SV orAV nodal areas are a primary cause of ineffectual contraction ofthe heart and subsequent death.
Representative arrhythmias include a rapid, but regular, atrial rate (atrialtachycardia),which in some instances may be associated with a premature beat, before the normal diastolictime interval has passed, resulting in an earlier and usually less effective ventricular beat. In atrial flutter and atrial fibrillation the atrial rate is even more rapid. Flutter refers to a condition in which a rapid depolarization ofthe right atrium appears to occur in a circle around its junction with the superior and inferiorvanae cavae (circus depolarization}; the resu ltantwave of electrical depolarization spreads out overthe surface of the atria, causing rapid atrial contraction.Fibrillation refers to an even faster rate, in which there is no coordinated activity; rather, it appears that each
small area of the muscle has a circus movement of its
own, thereby producing no effectual contraction. In
atrial fibrillation, the atrial rate is so fast that the
ventricles respond at totally irregulartimesto an
occasional impulse passing through the AV node.
The ventricular rate may not be the same as the
atrial rate; i.e., the atrial beat may not be propagated
through the AV node to the ventricle, or, contrariwise, the ventricle may initiate extra beats. If beat originates in the ventricles, the resultant pattern of
depolarization is abnormal. Ventricular premature
beats or permatureventricularcontractions (PVC's), are instances in which a single beat-or a short run
of beats-occurs abnormally from a ventricular
pacemaker site. If the ventricle is still in a depolarized
statewhenthe nextatrial depolarization wave
reaches it, there will be no response, and a com pensatory pause will occuruntil the second normal atrial beat arrives.Rapidly firing ventricular sites produce ventricular tachycardia, an extremely
dangerous condition, which may progress to ven
tricularfibrillation. In this condition no coordinated
contraction occurs, andthusthere is no effective
pumping of blood. This may be treated effectively
only by electrically depolarizing the entire heart
muscle (defibrillating) and hoping to restartitfrom a
single pacemaker site.
While advances in medical science have succeeded
in counteracting some effects of such abnormalities, devices such as pacemakers have proved not entirely
effective in regulating cardiac contractions, and are
known in some instances to actually induceventricu
larfibrillation. Further, heart transplants have had
disappointing results, and are also extremely expen sive.
This invention provides an artificial heartandlora natural heart strengthening device, useful either
corporally or extracorporally, comprising compress
or means associated with a mammalian heart for compressing the cardiac muscle to simulate the
normal pumping action thereof, and control means
forelectromagneticallycontrolling the operation of
said compressor means.
It is accordingly an object of this invention to
provide an artificial heart or heart strengthening
device to simulate the natural heart pulsation of
mammals by electromagnetic means which may
operate alone or in conjunction with the natural heart.
It is a further object ofthis invention to provide an
electromagnetized artificial heart including means for
generating and controlling electromagnetic induc tion fields to induce pulsatory motion for pumping
blood comparableto that ofthe natural mammalian
heart.
It is an additional object of the invention to provide an artificial heart which controls ventricular fibrilla- tion ofthe heart muscle by electromagnetic means.
It is yet another object of the invention to provide an
artificial heart which is electrically-synchronized with
the natural sino-auricular or auricular-ventricular nodal activityforconcerted action of the natural and
artificial hearts.
It is still further an object of this invention to provide
an artificial heartwhich is simple and effective in
alleviating the ravages of heart disease throughout the world.
It is still another object of this invention to provide an artificial heart which is flexible in operation.
Fig. 1 isaperspectiveviewoftheartificial heart device of the invention;
Fig. 2 is a schematic diagram of the artificial heart of
Fig.1;
Fig. 3 is a view similar to that of Fig. 1 illustrating an alternate embodiment of the device of the invention;
Fig. 4 is a schematic illustration of a further embodiment of the device ofthe invention;
Figs. 5 and 6 schematically illustrate exemplary control means and actuating meansforthedevice of the invention; Fig 7 is a schematic illustration of the artificial heart of the invention;
Fig. 8 schematically represents the operating scheme of the artificial heart of Fig. 7;
Fig. 9 illustrates schematically an alternate embody ment of the artificial heart of Fig. 7; and
Fig. loins a schematic illustration of an exemplary actuating meansforthe artificial heart of Fig. 9.
Schematic of Fig. 2 illustrates method of compressing the Aorta and other blood carrying vessels to assistthe circulation of blood.
With particularreferenceto Fig. 1,a mammalian heart compressing a cardiac muscle is schematically illustrated at 1, showing the associated major coron ary vessels compressing the superior vena cava 2, the interiorvena cava 3, the pulmonary artery4,the pulmonaryvein 6 and the aorta 7 and other vessels
(not designated). The artificial heart device of the invention, generally designated at 8, is shown in association with the heart 1.The device 8 includes compressor means generally indicated at 10for compressing the cardiac muscle 1 to simulate normal pumping action of this muscle, comprising first and second compressor components 9 and 11 disposed on the surface of the heart t and conforming to the contoursthereof. The components 9 and 10 are disposed so that they are in spaced relationship as shown, when the heart 1 is relaxed, or in a rest mode and so that they are in mating relationship when the heart 1 is in a pumping mode (contracted); preferably the components 9 and 10 are pivotallyjoined, as by a hinge 15. In the illustrated embodiment, the components Sand 10 are fabricated from sheets of a metal such as steel, gold, or platinum, perforated to reduce theweightthereof, or stainless steel net. Alternate materials include biocompatible-plastics such as polyurethane, silicone or natural or synthetic rubber, optionally impregnated with particles of a ferrous metal oran alloy thereof.
The device 8 further includes control means generally indicated at 12 for electromagnetically controlling the operation of compressor means 10, comprising a plurality of electromagnets 13 disposed on compressor component 9. Each electromagnet 13 includes an active pole element 14 disposed for electromagnetic interaction with a corresponding passive pole element 16 disposed on second com pressorcomponentl I when the electromagnets 13 are actuated. Actuating means generally indicated at 14 for actuating the electromagnets 13 comprises an electrical circuit 16 including a powergeneratorsuch as a rechargeable battery 17 and a transformer 18for regulating the amountof power and currentsupplied to the electromagnets 13 by the battery 17.Preferably, the circuit 16 further includes vibratory means such as a vibrator 19 for regulating the actuations of the electromagnets 13to provide a pulsating current in the circuit 16 of, for example, 50 to 200 pulses per minute to correspond with the natural pulsations of the heart 1. The vibrator 19, or other electric vibratory means similar to an electric door bell condenser and battery arrangement, such as a rotary motor having suitable distribution contacts or an alternating vibratory current or vibratory unit, is controlled by an on/off switching mechanism 21. The device 8 may further include means generally indicated at 22 for triggering the SAorAV nodal activity ofthe heart 1.
The device 8 of Fig. 1 is schematically illustrated in
Fig. 2,further including a coil delay unit 23. An exemplary supporting system for supporting the device 8 within the mammalian body is illustrated in
Fig. 3, comprising a supportive loop 24 secured to ribs 26 and carrying spring-loaded hinges 15a pivotally connecting compressor components 9 and 11, and biasing them in the resting mode illustrated. The compressor components or shrouds 9 and 11 may, in an alternate embodiment (not illustrated) be divided into four segments adjacent or alternating with the active or passive pole elements 14 or 16, respectively; the segments may, if desired, be associated only with the ventricular portions of the heart 1.
In operation,the switching mechanism 21 is activated, and current is generated by the battery 17 and supplied to the electromagnets 13 as regulated bythevibratorl9.Astheelectromagnets 13 are energized, the associated active pole elements 14 are activated, attracting corresponding pole elements 16.
Thecompressorcomponents9and 11 arethus pivotally drawn together on hinge 1 5to thereby compress the heart 1 andforce bloodthroughthe associated vessels 2-7 in a rhythm according to the pulsating current supplied through the circuit 16.
When the switch 21 is turned off, the electromagnets 13 are de-activated, andthe heart 1 returns to the normal position illustrated in Fig. 1 by its natural resilience optionally assisted by hinges 15a (Fig. 3) spring biasing com ponents 9 and 11 into spaced relationship. The action of components 9 and 11 are optionally synchronized with the natural SA and AV nodal rhythms ofthe heart 1 by current supplied by vibrator 19 to the triggering mechanism 22 simul taneously with the actuation of electromagnets 13.
In an alternate embodiment of the invention illustrated in Fig.4, an electromagnet 13a is disposed outside the mammalian body, partially defined by body wall 26. On actuation ofthe electromagnet 13a, associated active pole elements 1 4a are activated to attract passive pole elements 1 6a and operate compressor component 11 a to compress the heart Ia. On de-actuation of the electromagnet 1 3a, the component 11 a is returned to open position as by spring 27 biasing the component 11 a in open position, as illustrated. The embodiment illustrated is particularly effective in controlling ventricularfibrillation by compression of the heart 1 byactuationofthe electromagnet 1 3a at a predetermined rate to elimin ate the fibrillation.This is accomplished bysequential activation of the vibrator (not shown) regulating cu rrentto the electromagnet 13a. Figs. Sand 6 illustrate schematicallythe control means 12 and actuating means 14 for the device 8 described supra in connection with Figs. 1-4. In the embodiment of
Fig. 5, numeral 28 designates a battery-operated small rotary motor for switching the electromagnets 13 on or off by its rotary motion through contacts 29 associated with mounting means 31. Fig. 6 illustrates schematically control and actuating means 12 and 14, respectively, useful in connection with the embodi mentillustrated in Fig. 4.
In a further embodiment of the invention, Fig. 7 illustrates an artificial heart incorporating the com pressormeans 10, control means 12,andactuating means 14Ofthe previous embodiments, here dis- posed, however, outside the mammalian body.
Referring to Fig. 7 in detail schematically illustrated is a pair of lungs 35 and a heart 1 b including right and left ventricles 33 and 34 respectively; right and left atria 36 and 37 respectively; and an aorta 7a. Also schematically illustrated is an artificial heart generally indicated at 38, including right and left ventricles 39 and 47, respectively; and rig htand left atria 42 and 43 respectively. The artificial heart 38 further includes control valves 44 and 46 for controlling the flow of blood between natural heartlbandartificialheart38.
The arrows indicate the flow of blood controlled by valves 44 and 46 through the natural and artificial hearts 1 and 38 brought about by electromagnets 13b and pole elements 14b by the magnetic attraction of pole elements 1 6b. Artificial heart 38 further includes connecting elements 47 and 48 between the pole elements 14b and 1 6b. A body wall 49 separates heart 1 6b and 38.
The mechanism of the artificial heart is operated by a vibratory unit 19b which operates the electromagnets 1 3b provided with pole elements 1 4b. A coil delay unit 23a controls the frequency of the vibratory movement and provides synchronism with the natural heart pulsations via switches 52 at, for example, 70 to 100 beats per minute.
It is apparent that when electromagnets 13b are energized by the vibratory unit 1 9b, they attract pole elements 1 6b and when de-energized, the artificial heart38will return to its normal position due to its natural resilience assisted by biasing springs 51. Pole elements 16b may project outside the body ofthe animal, for example, by creating a non-leakable arrangement by surrounding the horizontal parts of connecting elements 47 and 48 supporting the pole elements, by a pole (not shown).
Thus, a rhythmic beat is created in unison with the natural heart 1 b. The letter "A" represents used blood from the body, and the letter "Z" indicates fresh blood supply to the body.
Figure 8 schematically illustrates the operating scheme of Fig. 7, wherein the heart 38 is placed outside the mammal's body. The numeral 49 representsthe bodywall and numeral 53the artificial metal or plastic platform supported by the ribs and the animal's body on which is mounted a plug 56 with a channel 57 for receiving blood from the body; a channel 58 for transferring into the lungs (not shown); a channel 59 for transporting blood from the lungs to
the left ventricle (not shown); and a channel 61 for
transference of the blood to the aorta (not shown).
Outside the body are situated corresponding chan
nels to the compressor means 1 Ob. Also shown is the
regulating vibrator 1 9cfor activating orswitching off
the compressor 1 orb. Numeral 1 7b represents a
battery, eliminator, or rechargeable battery for sup
plying the appropriate power for the operation of the
artificial heart 38.
Figure 9 iilustrates a similar a rtificial heart38b.A channel 62 equipped with a control valve 63 receives
blood from the body; a diaphragm 64 is fitted with a
valve 66; 65 is the fulcrum of diaphragm 64. Avalve 67 controls blood being pumped to the lungs 35; and
channel 68 supplies blood to the lungs 35. As the
electromagnets 1 3c are energized from vibrator 1 7c,
the pole elements 14c become magnets and attract
diaphragms or extensions 64 and 69 alternately; the
movement of the diaphragms 64 and 69 is indicated
by the arrows.
Similarly, blood received from the lungs 35 at 72 is forced by diaphragm 69 including valve 64, and
assisted by controlling valve 71; 68 represents the
fulcrum of diaphragm 69. The movement of the
diaphragm 69 is indicated by arrows as it is actuated
by electromagnets 13c and pole elements 14c. The blood isthus pumped to the aortas 7c and controlled
byvalve 73.
Figure 10 is a power supply diagram illustrating the
electrical power supplied to vibrator 1 9d, which can
be adjusted to vibrate atfrequencies ranging from about 50to 200.
The power supply system illustrated includes a coil
74, an electromagnetic coil 76 and pole elements 1 4d
which alternately attract movable pole elements 1 6d
coupled to a spring 77, which may be replaced by an
electromagnet 13d. In this embodiment, the numeral
49a represents the body wall.
Various components outside the body may be
enclosed in a suitably shaped container provided
with several vacuum cups to hold it in position
assisted by a brassiere or a holster.
Body tissues may be rendered capable of being
attracted to a magnet by superimposing stainless
steel gauze ora thin stainless steel plate by a surgical
operation, or by depositing very fine stainless steel
filings inside the animal tissue by projecting them
from an injector gun.
It is apparentthatthe natural and artificial hearts 1
and 38 may be used in conjunction with one another,
or singly operated by control means 12 described
supra.
Claims (16)
1. An artificial heart device incorporating means
for generating and controlling electromagnetic fields
by alternate activation and switching off of electro
magnetic and associated apparatus control means to render pulsatory compressor motion or movement
for pumping blood similarto a mammalian heart.
2. An artificial heart device comprising compress
or means associated with a mammalian heartfor compressing the cardiac muscleto simulatethe normal pumping action thereof and control means forelectromagnetically controlling the operation of said compressor means.
3. The invention of claims 1 and 2, wherein at least compressor means are juxtaposed with said heart muscle.
4. The invention of claims 1 and 2, wherein the said device is disposed outside the mammalian body.
5. The invention of claims 1 and 2, wherein said control means functions to synchronize the action of said compressor means with the atrial and ventricular rhythmic contraction ofthe normal heart.
6. The invention of claims 1 and 2, wherein said compressor means comprise a pair of first and second compressor components disposed on the surface of the heart in spaced relationship for electromagnetic interaction to compress said cardiac muscle on actuation of said compressor means.
7. The invention of claim 6, wherein each of said components comprises a metal sheet conforming to a portion ofthe said heart muscle.
8. The invention of claim 6, wherein the first compressor component includes a set of pole elements disposed for electromagnetic interaction with a set of corresponding pole elements on the second compressor component.
9. The invention of claims 1, 2 and 8 wherein the actuation of the said pole elements is regulated by vibratory means for producing rhythmic electromagnetic interaction of said pole elements to compress said cardiac muscle synchronisticallywith the normal pumping action.
10. The invention of claims 1 and 2,whereinthe control means comprises of an electromagnet disposed outside the mammalian body and said compressor means comprises a compressor component disposed adjacent to the heart within the body for electromagnetic interaction with said control means to rhythmically compress said cardiac muscle and simulate the normal pumping action of the heart in responsetothe electrical actuation of said electromagnet.
11. The invention of claims 1 and 2, wherein said device supplements the action of a defective heart muscle.
12. The invention of claims 1 and 2, wherein said device replaces the inherent action of the mammalian heart.
13. An artificial heart for affecting blood circulation within a mammalian body comprising a) means for receiving blood from the body, and transferring means for transferring this received blood to the lungs; and b) means for receiving blood from the lungs and transferring means fortransferring this received blood to the aorta, said transferring means comprising electromagnetically operated compressor meansfor pumping blood thus received.
14. The invention as claimed in claims 1 and 2, wherein the compressor means are utilized for compressing the aorta and otherbloodvessals associated with the mammalian heart.
15. An artificial heart device as claimed in any of the previous claims, wherein the body tissues are capable of being attracted by an electromagnet by superimposing stainless steel gauze or plate fabri cated from said metal or by depositing very fine stainless steel filings inside the animal tissues by projecting them from an injector gun.
16. An artificial heart device as described and illustrated in the accompanying drawings.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08218603A GB2115287B (en) | 1981-06-29 | 1982-06-28 | Devices for replacing or assisting the heart |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8119920 | 1981-06-29 | ||
| GB8200231 | 1982-01-06 | ||
| GB8200974 | 1982-01-14 | ||
| GB08218603A GB2115287B (en) | 1981-06-29 | 1982-06-28 | Devices for replacing or assisting the heart |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2115287A true GB2115287A (en) | 1983-09-07 |
| GB2115287B GB2115287B (en) | 1985-10-30 |
Family
ID=27449256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08218603A Expired GB2115287B (en) | 1981-06-29 | 1982-06-28 | Devices for replacing or assisting the heart |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2115287B (en) |
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4314269A1 (en) * | 1993-04-30 | 1994-11-03 | Georg Dr Berg | Device for supporting the heart and/or for replacing myocardial power |
| US5800528A (en) * | 1995-06-13 | 1998-09-01 | Abiomed R & D, Inc. | Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation |
| WO2000012152A1 (en) * | 1998-08-28 | 2000-03-09 | Juan Hernandez Herrero | Apparatus aiding physiologic systolic and diastolic dynamics of cardiac cavities |
| US6432039B1 (en) | 1998-12-21 | 2002-08-13 | Corset, Inc. | Methods and apparatus for reinforcement of the heart ventricles |
| US6540659B1 (en) | 2000-11-28 | 2003-04-01 | Abiomed, Inc. | Cardiac assistance systems having bi-directional pumping elements |
| US6547716B1 (en) | 2000-11-28 | 2003-04-15 | Abiomed, Inc. | Passive cardiac restraint systems having multiple layers of inflatable elements |
| US6572534B1 (en) | 2000-09-14 | 2003-06-03 | Abiomed, Inc. | System and method for implanting a cardiac wrap |
| US6602182B1 (en) | 2000-11-28 | 2003-08-05 | Abiomed, Inc. | Cardiac assistance systems having multiple fluid plenums |
| US6616596B1 (en) | 2000-11-28 | 2003-09-09 | Abiomed, Inc. | Cardiac assistance systems having multiple layers of inflatable elements |
| US6626821B1 (en) | 2001-05-22 | 2003-09-30 | Abiomed, Inc. | Flow-balanced cardiac wrap |
| US6695769B2 (en) | 2001-09-25 | 2004-02-24 | The Foundry, Inc. | Passive ventricular support devices and methods of using them |
| US6846296B1 (en) | 2000-09-14 | 2005-01-25 | Abiomed, Inc. | Apparatus and method for detachably securing a device to a natural heart |
| US7060023B2 (en) | 2001-09-25 | 2006-06-13 | The Foundry Inc. | Pericardium reinforcing devices and methods of using them |
| US7097611B2 (en) | 2000-03-10 | 2006-08-29 | Paracor Medical, Inc. | Expandable cardiac harness for treating congestive heart failure |
| US7146226B2 (en) | 2003-11-07 | 2006-12-05 | Paracor Medical, Inc. | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
| US7158839B2 (en) | 2003-11-07 | 2007-01-02 | Paracor Medical, Inc. | Cardiac harness for treating heart disease |
| US7174896B1 (en) | 2002-01-07 | 2007-02-13 | Paracor Medical, Inc. | Method and apparatus for supporting a heart |
| US7189203B2 (en) | 2002-11-15 | 2007-03-13 | Paracor Medical, Inc. | Cardiac harness delivery device and method |
| US7229405B2 (en) | 2002-11-15 | 2007-06-12 | Paracor Medical, Inc. | Cardiac harness delivery device and method of use |
| US7276021B2 (en) | 2001-10-31 | 2007-10-02 | Paracor Medical, Inc. | Heart failure treatment device and method |
| US7282024B2 (en) | 2004-01-12 | 2007-10-16 | Paracor Medical, Inc. | Cardiac harness having interconnected strands |
| US7291105B2 (en) | 2003-07-10 | 2007-11-06 | Paracor Medical, Inc. | Self-anchoring cardiac harness |
| US7381181B2 (en) | 2001-09-10 | 2008-06-03 | Paracor Medical, Inc. | Device for treating heart failure |
| US7485089B2 (en) | 2002-09-05 | 2009-02-03 | Paracor Medical, Inc. | Cardiac harness |
| US7587247B2 (en) | 2005-08-01 | 2009-09-08 | Paracor Medical, Inc. | Cardiac harness having an optimal impedance range |
| US7736299B2 (en) | 2002-11-15 | 2010-06-15 | Paracor Medical, Inc. | Introducer for a cardiac harness delivery |
| US7976454B2 (en) | 2002-01-07 | 2011-07-12 | Paracor Medical, Inc. | Cardiac harness |
| US8192351B2 (en) | 2007-08-13 | 2012-06-05 | Paracor Medical, Inc. | Medical device delivery system having integrated introducer |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6702732B1 (en) | 1999-12-22 | 2004-03-09 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
-
1982
- 1982-06-28 GB GB08218603A patent/GB2115287B/en not_active Expired
Cited By (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4314269A1 (en) * | 1993-04-30 | 1994-11-03 | Georg Dr Berg | Device for supporting the heart and/or for replacing myocardial power |
| US5800528A (en) * | 1995-06-13 | 1998-09-01 | Abiomed R & D, Inc. | Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation |
| US6224540B1 (en) | 1995-06-13 | 2001-05-01 | Abiomed, Inc. | Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation |
| US6508756B1 (en) | 1995-06-13 | 2003-01-21 | Abiomed, Inc. | Passive cardiac assistance device |
| WO2000012152A1 (en) * | 1998-08-28 | 2000-03-09 | Juan Hernandez Herrero | Apparatus aiding physiologic systolic and diastolic dynamics of cardiac cavities |
| US6432039B1 (en) | 1998-12-21 | 2002-08-13 | Corset, Inc. | Methods and apparatus for reinforcement of the heart ventricles |
| US7189202B2 (en) | 2000-03-10 | 2007-03-13 | Paracor Medical, Inc. | Self-sizing cardiac harness for treating congestive heart failure |
| US7410461B2 (en) | 2000-03-10 | 2008-08-12 | Paracor Medical, Inc. | Cardiac treatment apparatus |
| US7097611B2 (en) | 2000-03-10 | 2006-08-29 | Paracor Medical, Inc. | Expandable cardiac harness for treating congestive heart failure |
| US7124493B2 (en) | 2000-03-10 | 2006-10-24 | Paracor Medical, Inc. | Method of manufacturing a cardiac harness |
| US6572534B1 (en) | 2000-09-14 | 2003-06-03 | Abiomed, Inc. | System and method for implanting a cardiac wrap |
| US6846296B1 (en) | 2000-09-14 | 2005-01-25 | Abiomed, Inc. | Apparatus and method for detachably securing a device to a natural heart |
| US6547716B1 (en) | 2000-11-28 | 2003-04-15 | Abiomed, Inc. | Passive cardiac restraint systems having multiple layers of inflatable elements |
| US6602182B1 (en) | 2000-11-28 | 2003-08-05 | Abiomed, Inc. | Cardiac assistance systems having multiple fluid plenums |
| US6616596B1 (en) | 2000-11-28 | 2003-09-09 | Abiomed, Inc. | Cardiac assistance systems having multiple layers of inflatable elements |
| US6540659B1 (en) | 2000-11-28 | 2003-04-01 | Abiomed, Inc. | Cardiac assistance systems having bi-directional pumping elements |
| US6626821B1 (en) | 2001-05-22 | 2003-09-30 | Abiomed, Inc. | Flow-balanced cardiac wrap |
| US7422558B2 (en) | 2001-09-10 | 2008-09-09 | Paracor Medical, Inc. | Device for treating heart failure |
| US7435213B2 (en) | 2001-09-10 | 2008-10-14 | Paracor Medical, Inc. | Device for treating heart failure |
| US7381181B2 (en) | 2001-09-10 | 2008-06-03 | Paracor Medical, Inc. | Device for treating heart failure |
| US7060023B2 (en) | 2001-09-25 | 2006-06-13 | The Foundry Inc. | Pericardium reinforcing devices and methods of using them |
| US7354396B2 (en) | 2001-09-25 | 2008-04-08 | The Foundry, Inc. | Passive ventricular support devices and methods of using them |
| US6695769B2 (en) | 2001-09-25 | 2004-02-24 | The Foundry, Inc. | Passive ventricular support devices and methods of using them |
| US7276021B2 (en) | 2001-10-31 | 2007-10-02 | Paracor Medical, Inc. | Heart failure treatment device and method |
| US7404793B2 (en) | 2001-10-31 | 2008-07-29 | Paracor Medical, Inc. | Heart failure treatment device and method |
| US7174896B1 (en) | 2002-01-07 | 2007-02-13 | Paracor Medical, Inc. | Method and apparatus for supporting a heart |
| US7976454B2 (en) | 2002-01-07 | 2011-07-12 | Paracor Medical, Inc. | Cardiac harness |
| US7485089B2 (en) | 2002-09-05 | 2009-02-03 | Paracor Medical, Inc. | Cardiac harness |
| US7572219B2 (en) | 2002-11-15 | 2009-08-11 | Paracor Medical, Inc. | Cardiac harness delivery device and method |
| US7189203B2 (en) | 2002-11-15 | 2007-03-13 | Paracor Medical, Inc. | Cardiac harness delivery device and method |
| US7338435B2 (en) | 2002-11-15 | 2008-03-04 | Paracor Medical, Inc. | Cardiac harness delivery device and method |
| US7229405B2 (en) | 2002-11-15 | 2007-06-12 | Paracor Medical, Inc. | Cardiac harness delivery device and method of use |
| US7361139B2 (en) | 2002-11-15 | 2008-04-22 | Paracor Medical, Inc. | Cardiac harness delivery device and method |
| US7736299B2 (en) | 2002-11-15 | 2010-06-15 | Paracor Medical, Inc. | Introducer for a cardiac harness delivery |
| US7500946B2 (en) | 2002-11-15 | 2009-03-10 | Paracor Medical, Inc. | Cardiac harness delivery device and method |
| US7291105B2 (en) | 2003-07-10 | 2007-11-06 | Paracor Medical, Inc. | Self-anchoring cardiac harness |
| US7149588B2 (en) | 2003-11-07 | 2006-12-12 | Paracor Medical, Inc. | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
| US7146226B2 (en) | 2003-11-07 | 2006-12-05 | Paracor Medical, Inc. | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
| US7155295B2 (en) | 2003-11-07 | 2006-12-26 | Paracor Medical, Inc. | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
| US7158839B2 (en) | 2003-11-07 | 2007-01-02 | Paracor Medical, Inc. | Cardiac harness for treating heart disease |
| US7225036B2 (en) | 2003-11-07 | 2007-05-29 | Paracor Medical, Inc | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
| US7164952B2 (en) | 2003-11-07 | 2007-01-16 | Paracor Medical, Inc. | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
| US7187984B2 (en) | 2003-11-07 | 2007-03-06 | Paracor Medical, Inc. | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
| US7282024B2 (en) | 2004-01-12 | 2007-10-16 | Paracor Medical, Inc. | Cardiac harness having interconnected strands |
| US7587247B2 (en) | 2005-08-01 | 2009-09-08 | Paracor Medical, Inc. | Cardiac harness having an optimal impedance range |
| US8192351B2 (en) | 2007-08-13 | 2012-06-05 | Paracor Medical, Inc. | Medical device delivery system having integrated introducer |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2115287B (en) | 1985-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4621617A (en) | Electro-magnetically controlled artificial heart device for compressing cardiac muscle | |
| GB2115287A (en) | Devices for replacing or assisting the heart | |
| US3587567A (en) | Mechanical ventricular assistance assembly | |
| US6604529B2 (en) | External electromagnetic system for assisting systolic and diastolic ventricular function, and method therefor | |
| US4666443A (en) | Biventricular circulatory assist system and method | |
| Carpentier et al. | Dynamic cardiomyoplasty at seven years | |
| CA2367500C (en) | Heart assist system employing magnetic repulsion force | |
| US6309341B1 (en) | Method for constructing an organ of an animal by employing bands with electromagnetic actuators | |
| US3455298A (en) | Instrument for direct mechanical cardiac massage | |
| EP1383554B1 (en) | Artificial heart | |
| US6464655B1 (en) | Electrically-controllable multi-fingered resilient heart compression devices | |
| US3233607A (en) | Automatic heart massage device | |
| US4192293A (en) | Cardiac assist device | |
| CN112933396B (en) | An electromagnetic heart beat assist device | |
| FR2669523B1 (en) | HEART FAILURE PREVENTION DEVICE | |
| JPH06504210A (en) | Cardiac assistance system with muscle power supply | |
| US5348528A (en) | Cardiac assist device | |
| US8372145B2 (en) | Implantable artificial ventricle having low energy requirement | |
| US20240157115A1 (en) | Device for assistance by direct cardiac compression | |
| US8241197B2 (en) | Method of generating a cardiogram with a magnet | |
| US8231517B2 (en) | Stabilization for electromagnetic biventricular assist device | |
| CN215135920U (en) | Electromagnetic heart beating assisting device | |
| US8231518B2 (en) | Cardiac diastolic augmentation improving cardiac output in electromagnetic biventricular assist device | |
| US20060009672A1 (en) | Atrial fibrillation treatment and method | |
| WO2003018084A2 (en) | Extra-pericardium heart assist device and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 746 | Register noted 'licences of right' (sect. 46/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |